Clue Genetics Acquires Rare Fungus Collection from Mycosynthetix.

MANews-(C)2009-2022

California, US-based biotechnology company Clue Genetics Inc. has acquired certain R and D assets of North Carolina, US-based biotechnology company Mycosynthetix, Inc., including its proprietary collection of approximately 50,000 diverse strains of fungi, the company said.

The acquisition brings together Clue's expertise in genomics and computational biology with MSX's complementary capabilities in fungal biology, natural product chemistry and pharmacology.

Following the deal, MSX's CEO, Dr. Cedric Pearce, will serve as president of Clue and will sit on its board of directors. Dr. OIiver...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT